6499.TWO Medeon Biodesign

Healthcare Health Care Equipment & Supplies Taiwan OTC Exchange
70.90 TWD
Close of Nov 6, 2026
55.80 134.00
Market cap
TWD 6.87B
P/E
-
P/B
5.64x
ROE
-40.1%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 2 quarters up to Jun 2026.

Is 6499.TWO undervalued?

Graham number

The Graham number of Medeon Biodesign cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

Medeon Biodesign fundamental analysis

No fundamental analysis for Medeon Biodesign yet.

Medeon Biodesign stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About Medeon Biodesign

Medeon Biodesign, Inc. engages in the research and development, manufacturing, and sale of medical devices in the United States. The company focuses on developing devices for minimally invasive surgeries, such as Cross-Seal, a large bore vascular closure system; Urocross, an expander system for treating lower urinary tract symptoms associated with benign prostatic hyperplasia; Duett, a vascular graft system; PUMA, solution to treat orthopedic extremity injuries; ClickClean, …

Full company profile